Susquehanna International Group’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Susquehanna International Group’s Portfolio OMED Stock Details OMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-29,600	Closed	-$273K	–	10459
2017 Q1	$273K	Buy	29,600 +17,000	+135%	+$149K	﹤0.01%	7494
2016 Q4	$97K	Sell	12,600 -45,100	-78%	-$414K	﹤0.01%	9099
2016 Q3	$660K	Buy	57,700 +25,600	+80%	+$298K	﹤0.01%	5551
2016 Q2	$395K	Sell	32,100 -28,200	-47%	-$342K	﹤0.01%	6517
2016 Q1	$610K	Buy	60,300 +21,400	+55%	+$251K	﹤0.01%	6045
2015 Q4	$877K	Sell	38,900 -20,700	-35%	-$424K	﹤0.01%	5678
2015 Q3	$989K	Buy	59,600 +5,800	+11%	+$116K	﹤0.01%	5785
2015 Q2	$1.21M	Buy	53,800 +35,500	+194%	+$875K	﹤0.01%	5791
2015 Q1	$472K	Buy	+18,300	New	+$464K	﹤0.01%	7210
2014 Q4	–	Sell	-82,100	Closed	-$1.55M	–	10674
2014 Q3	$1.55M	Buy	+82,100	New	+$1.65M	﹤0.01%	5069

Susquehanna International Group's OMED Position: Q2 2019 in Review

Susquehanna International Group sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q2 2019, closing a stake of 14,993 shares — an estimated $16K sold.

Susquehanna International Group first reported a position in OMED in Q4 2014 and held it in 12 quarters. The position peaked at $810K in Q1 2015. 0 funds tracked by Wall St. Rank hold OMED as of Q2 2019.

Susquehanna International Group reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
Susquehanna International Group sold 14,993 OncoMed Pharmaceuticals, Inc. shares in Q2 2019, an estimated $16K.
Susquehanna International Group first reported a position in OncoMed Pharmaceuticals, Inc. in Q4 2014 and held it in 12 quarters.
Susquehanna International Group's OncoMed Pharmaceuticals, Inc. position peaked at $810K in Q1 2015.
0 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2019.

Based on Susquehanna International Group's 13F filing for Q2 2019, filed 14 Aug 2019.